Related Experiment Video
Updated: Aug 11, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
COVID-19 and autoimmune bullous diseases: Lessons learned
Michael Kasperkiewicz1, David T Woodley1
1Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Abstract:
Both COVID-19 and autoimmune bullous diseases represent potentially life-threatening conditions. Autoimmunity has been a special focus during the COVID-19 pandemic considering the possible detrimental mutual influence between COVID-19 and autoimmune disorders as well as their supposed induction or triggering by SARS-CoV-2 vaccines. There is a growing need to assess the impact of the current pandemic particularly in patients with autoimmune bullous diseases requiring potent and long-term immunosuppressive treatments. This review provides the relevant state-of-the-art knowledge, including our own research, about immunobullous diseases in relation to COVID-19 and summarizes expert perspectives on their management throughout the pandemic.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Myocarditis III: Medical Management
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cross-reactivity
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

